Production (Stage)
Eledon Pharmaceuticals, Inc.
ELDN
$2.87
-$0.13-4.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.50M | -44.62M | 76.97M | -44.91M | -23.63M |
| Total Depreciation and Amortization | -- | 88.00K | 79.00K | 97.00K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -7.81M | 27.06M | -95.62M | 33.88M | 14.63M |
| Change in Net Operating Assets | -1.75M | -1.52M | 6.80M | 3.16M | 265.00K |
| Cash from Operations | -16.06M | -18.99M | -11.77M | -7.77M | -8.74M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.89M | -47.38M | -12.80M | -19.91M | 9.78M |
| Cash from Investing | 3.89M | -47.38M | -12.80M | -19.91M | 9.78M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 115.00K | 80.17M | 5.28M | 48.07M | 1.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 115.00K | 80.17M | 5.28M | 48.07M | 1.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.05M | 13.80M | -19.29M | 20.38M | 1.04M |